“…However, although they are very similar, they behave differently. The follicular, subtype presented by the patient in the case, tends to be more aggressive, has higher mortality rates and is, more often, diagnosed in more advanced stages of the disease when compared with papillary carcinoma [9]. Still under this comparison, FTC is even more vascularized and, therefore, releases metastases more frequently, in a rate of 15%-27% of patients and the most affected sites are the bones and lungs [6].…”